Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

This strong performance highlights investor confidence in Vertex's innovative tax compliance solutions, strategic partnerships and expanding client base. The increasing adoption of e-invoicing ...

Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, was recognized on ...

Orna Therapeutics, through its wholly owned subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with ...

Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...

Vertex Global Services partners with Arish Global Services to create 5,000 jobs in Delhi-NCR, focusing on business process ...

Fulton Bank N.A. decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 5.6% ...

Vertex, Inc. (NASDAQ:VERX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the thirteen research firms that are covering the company, MarketBeat.com reports. Four ...

To help retailers address challenges such as rising costs, supply chain disruptions, pricing pressures, and employee turnover ...

Detailed price information for Vertex Resource Group Ltd (VTX-X) from The Globe and Mail including charting and trades.

Vertex Global Services partners with UK-based Arish Global Services to create over 5,000 jobs in India, boosting the ...